XTalks

JANUARY 23, 2024

Lumos Pharma’s endeavors in developing novel treatments for PGHD and other diseases underscore a broader mission: to provide hope and improved quality of life for patients who have long awaited effective and accessible treatments. Pediatric growth hormone deficiency (PGHD) is one such condition, affecting a child’s growth and development.

Development 72

Development Hormones Drugs Trials 72

pharmaphorum

OCTOBER 31, 2022

Between the 2nd and 4th November, a veritable who’s who of British industry will gather at the Eden Project in Boldeva, Cornwall for Anthropy 2022, the event’s second year. A Vision for Britain.’. A Vision for Britain.’. The singular purpose of them all? ‘A These events are all pertinent to the pharmaceutical sphere.

Production 84

Production 84

XTalks

JUNE 10, 2022

We represent our members, national and local Parkinson’s organizations, who in turn advocate for more than 1.2 We represent our members, national and local Parkinson’s organizations, who in turn advocate for more than 1.2 million people living with Parkinson’s in Europe. Read on to learn more!

Research 98

Research Trials Clinical Trials Clinical Trials 98

pharmaphorum

APRIL 25, 2022

“Up until that point, we both had this vision that [VR therapeutics] was something that ought to exist. “Up until that point, we both had this vision that [VR therapeutics] was something that ought to exist. We just hadn’t found each other. Configuring a collaboration.

Behavioural Health 96

Behavioural Health Production Clinical Trials Clinical Trials 96

pharmaphorum

MAY 16, 2022

Digital Strategy and Digital Health Vision. In 2020, USAID launched two policy documents to guide how the agency invests in digital infrastructure as part of its development and humanitarian assistance programmes: Digital Strategy and Vision for Action in Digital Health (aka Digital Health Vision).

Development 99

Development Life Science Vaccination Vaccine 99

Intouch Solutions

OCTOBER 20, 2021

Intouch shares our vision and hearty appetite for disruption. Together, we will engage the entire life sciences ecosystem in new and powerful ways. Who better than EVERSANA and Intouch to actually change the game and improve healthcare worldwide?”. With EVERSANA, our team takes a monumental step forward.

Life Science 98

Life Science Marketing Production Branding 98

pharmaphorum

DECEMBER 11, 2022

As we develop these technologies, it’s not only that we must focus on the patient experience; we need to start with the patient experience,” Hadjiat tells pharmaphorum. This is a real shift in how we diagnose, monitor, and treat MS. Digital transformation in pharma is not a singular endeavour.

Life Science 132

Life Science Clinical Research Development Research 132

CTTI (Clinical Trials Transformation Initiative)

JANUARY 9, 2023

These new members of the PEC include patients who have personal disease experience, caregivers who have personal experience supporting someone with a health condition, and representatives from patient groups who have direct or indirect disease experience. Today, the U.S. The eight new representatives are: . Kim Hindery .

Clinical Trials 81

Clinical Trials Clinical Trials Trials Production 81

XTalks

DECEMBER 16, 2021

We are excited that our investors are partnering with us to create the next generation of plant-based – real foods, from a real plant,” said the company’s CEO and founder Annie Ryu, in a press release. “We So, how did Jack & Annie’s earn millions from investors and what will it do with the funding? “We to $7.99.

Branding 90

Branding Production Medicine Marketing 90

pharmaphorum

MAY 23, 2022

This article follows part one of our two-part series, in which we discussed how USAID invests in digital infrastructure as part of its development and humanitarian assistance programmes. . There are many roles for partners alongside our work,” Waugaman states.

Development 79

Development Life Science Production Manufacturing 79

XTalks

NOVEMBER 6, 2023

Enter the Xtalks’ Talent Acquisition & Branding Bundle (TABB) — a multifaceted solution designed to elevate your organization’s visibility, profile and allure within our globally-renowned community in the life sciences industry. Ready to get started with the Talent Acquisition & Branding Bundle?

Branding 52

Branding Life Science HR Marketing 52

pharmaphorum

FEBRUARY 17, 2021

trillion health economy in the United States shed billions in value overnight. “The trillion health economy in the United States shed billions in value overnight. He told his guests, “We are not happy with healthcare costs and want to help.” CVS Health, Walmart, Cardinal Health and Express Scripts were among those affected.

Marketing 123

Marketing Life Science Pharmacy Branding 123

pharmaphorum

OCTOBER 5, 2021

In recent years, we have seen thinking shift from focusing on a disease’s treatment to seriously considering the wider potential for its prevention, enabled by dramatic advances in data science and supported by a pressing need to reduce healthcare costs. The traditional patient role is rapidly changing.

Doctors 121

Doctors Doctor Marketing Development 121

pharmaphorum

NOVEMBER 25, 2021

Brands] need to be very targeted and clear on who their audience is and how they want to participate. “[Brands] need to be very targeted and clear on who their audience is and how they want to participate. The changing events model. Knowing and correctly targeting your audience is key,” Sherlock-Goudet says.

Pharma Companies 98

Pharma Companies Production Sales Marketing 98

pharmaphorum

FEBRUARY 2, 2022

Last month, it also bought Impeto Medical to claim ownership of its Sudoscan device for detecting nerve damage affecting patients with diabetes or those who are getting chemotherapy for cancer. It operates in a category that includes rival fitness and diet apps from the likes of Noom, MyFitnessPal and Cronometer.

Production 63

Production Marketing Development 63

Drug Discovery World

MARCH 13, 2024

Singapore is among a few countries worldwide whose pharmaceutical export value far exceed the import value. With government support and strong academic institutions, does Singapore have what it takes to become a global centre for life sciences?

Life Science 69

Life Science Genome Genomics Research 69

pharmaphorum

MAY 19, 2021

The addition to the hi.health app acts as a digital health expense account, according to the company’s co-founder and chief scientific officer Fredrik Debong, who was a co-founder of diabetes management app mySugr.com, which was snapped up by Roche in 2017.

Pharmacy 103

Pharmacy Marketing Medicine 103

The Pharma Data

APRIL 22, 2023

WHO releases new guide on developing national programmes for age-friendly cities and communities As population ageing and urbanization rapidly progress worldwide, making our cities and communities more age-friendly is crucial to maximise the opportunities offered by longer lives. The guide covers the following areas.

Development 40

Development 40

The Pharma Data

OCTOBER 27, 2020

Stargardt disease is a devastating genetic disorder that affects central vision with no approved treatment options. . “This designation permits reVision to further accelerate the development of our Stargardt disease treatment. . RIDGEWOOD, N.J. , 28, 2020 /PRNewswire/ — ReVision Therapeutics, Inc.,

Drugs 52

Drugs Genetics Licensing Licensing 52

The Pharma Data

APRIL 7, 2023

This investment includes a new seed dryer, state-of-the-art agricultural field equipment, storage facilities and the construction of two bomb shelters to ensure the safety of the Ukrainian colleagues who have been operating the facility and executing this investment project under very difficult circumstances. We stand with Ukraine.

Production 40

Production Life Science Branding Sales 40

pharmaphorum

NOVEMBER 2, 2022

That’s the view of BTIG analyst Marie Thibault, who reckons the $380 per share cash offer – a 50% premium on Abiomed’s pre-deal closing price – will serve as a deterrent to other interested parties. The Abiomed deal includes a contingent value right of $35 per share which is tied to the certain commercial and clinical milestones.

Sales 52

Sales Manufacturing Marketing 52

pharmaphorum

JUNE 7, 2021

We are seeing more focus on personalised, omni-channel marketing and on patient centricity, and silos are being broken down. A lot of the traditional norms are being questioned and reshaped as we speak.”. “A A lot of the traditional norms are being questioned and reshaped as we speak.”.

Sales 81

Sales Marketing Doctors Doctor 81

Drug Discovery World

FEBRUARY 24, 2023

Now, she thinks people are starting to move into AI and ask, ‘if we could consume more data in a way that’s going to provide better insight, why would we not be doing that?’ At SLAS, we get to be on the bleeding edge, and hear those sorts of talks. She will be chairing a session at SLAS2023.

Life Science 52

Life Science Drugs Bioinformatics Development 52

pharmaphorum

SEPTEMBER 6, 2022

We believe that companies like Bayer consumer health have a responsibility to provide trustworthy, evidence-based solutions to the consumer’s non-prescription healthcare needs, using our deep understanding of biology and consumer needs to deliver innovative products – and keeping on top of changing needs and paradigms.

Production 67

Production Regulation Compliance Research 67

pharmaphorum

MAY 20, 2022

We recruited a large number of patients to commercial and non-commercial studies. Now, we are hoping that we can maintain the momentum and continue in the same way.”. “Now, Now, we are hoping that we can maintain the momentum and continue in the same way.”. Developing the vision for the primary care setting.

Research 58

Research Clinical Trials Clinical Trials Clinical Research 58

The Pharma Data

OCTOBER 28, 2021

” Right now, these leaders know that people do n’t have access to the same healthcare grounded on where they live, how important plutocrat they make or the colour of their skin-what we’re missing is cohesive action. .

Development 52

Development Drugs Research 52

The Pharma Data

MARCH 22, 2022

Affini-T is committed to developing potentially life- changing drugs for cases with intractable solid excrescence cancers, who represent a critical unmet need as current treatment options warrant continuity and efficacity. Co-founded at Fred Hutchinson Cancer Research Center with Phil Greenberg, M.D., Aude Chapuis, M.D., and Jak Knowles, M.D./

Engineer 52

Engineer Development Licensing Licensing 52

pharmaphorum

DECEMBER 1, 2021

Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional and global life science communications to offer some little tips for enjoying a big business career. This post looks at people manager effectiveness and how to boost team and co-worker engagement. Everyone’s a manager.

Life Science 100

Life Science Sales Development Production 100

The Pharma Data

JANUARY 12, 2021

History is being written today as we embark on our ambitious mission to kickstart the renaissance in oncology clinical trial enrollment. NEW YORK–( BUSINESS WIRE )– Massive Bio, Inc. , This press release features multimedia. View the full release here: [link]. Co-founder and CEO of Massive Bio. “The

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

The Pharma Data

MARCH 5, 2021

per share in cash, representing an equity value of approximately $1.9 “The acquisition of Five Prime offers a compelling opportunity for Amgen to strengthen our oncology portfolio with a promising late-stage, first-in-class global asset to treat gastric cancer,” said Robert A.

Antibody 52

Antibody Trials Development Clinical Development 52

The Pharma Data

MARCH 31, 2023

Demonstrating the efficacy of a biologic treatment for this inflammatory condition is important for a group of patients who have previously had no treatment option once antibiotics are no longer effective.” Inflammation of the ileal pouch, pouchitis, can cause fecal incontinence, abdominal discomfort, and bleeding. difference; p=0.01).

Medicine 40

Medicine Vaccination Vaccine Clinical Trials 40

Pharma Marketing Network

JUNE 11, 2020

RJ Lewis (EHS): Hello, this is RJ Lewis and we’re back for Episode 2 with John Mack and Don Langsdorf, and we’re talking about the rebirth of Pharma Marketing and Pharma Guy. The thing that’s probably going to be the most different about what you were doing and what we were doing. That’s our vision.

Marketing 52

Marketing Branding Regulation Production 52

Delveinsight

AUGUST 24, 2021

Senior Vice President, Head of Development and Safety, Alexion, said: “We are disappointed by this outcome and what it means for patients with this devastating disease. We would like to thank the entire ALS community as well as investigators and healthcare professionals who dedicated their time and expertise to this trial.

Clinical Trials 96

Clinical Trials Clinical Trials Trials Drugs 96

The Pharma Data

DECEMBER 11, 2020

“Pfizer’s purpose is breakthroughs that change patients’ lives, and in our 171-year history there has never been a more urgent need for a breakthrough than today with hundreds of thousands of people continuing to suffer from COVID-19,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. . immediately.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

Pharma Business Blog

MARCH 9, 2020

History shows that those who plan and act decisively at speed during such crises emerge as winners in their industry. 1 – Have a clear vision of direction and be prepared to flex your muscles to make it happen. While the economic impact is unknown scenario planning is key. Focus on reliable data. Adjust your financial plan.

HR 52

HR Life Science Marketing Production 52

XTalks

JANUARY 18, 2024

Xtalks interviewed Peter Maag, PhD, CEO of Kyverna Therapeutics, who shares insights into Kyverna’s dedication to transforming the treatment landscape for autoimmune conditions through differentiated cell therapies. And right now, we are finding out through our clinical trial program which patients may benefit.

Clinical Trials 124

Clinical Trials Clinical Trials Trials Life Science 124

pharmaphorum

SEPTEMBER 18, 2020

We take a look at the company’s story, from its creation as a merger of two equals, to its recent major restructuring and its drives in cutting-edge oncology and COVID-19. AstraZeneca is a company with a turbulent history but, for now, a promising future. However, this new name has since caused confusion between Prilosec and Prozac.

Pharma Companies 115

Pharma Companies Sales Vaccination Vaccine 115